FDA approves wider rosuvastatin label
Links shared publicly online about this topic.
- 1,396total visits
FDA approves wider rosuvastatin label
UPDATED WITH COMMENTARY // The FDA decision was announced Monday. Eligible patients for statin therapy now include those who qualify based on age, elevated hs-CRP, and one additional cardiovascular risk factor, a label that one expert considers
View full resource at theheart.org
Tags: Cholesterol Medication, FDA, Crestor
Most Recently Shared on February 9, 2010 at 2:03 am By:
FDA approves expanded rosuvastatin label: The FDA's decision was announced late Monday. For complete story visit t... http://bit.ly/bzysE4
FDA rejects wider use of Merck's Gardasil - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA declined to approve Merck & Co.'s Gardasil for women ages 27 to 45, saying the vaccine has not been proven effective for this age group in preventing cervical cancer associated with human papillomavirus. Labeling for Gardasil was updated to reflect the agency's decision. Gardasil is approve--” View full resource at smartbrief.com
Most Recently Shared on April 7, 2011 at 3:13 pm By:
FDA rejects wider use of Merck's Gardasil. http://sbne.ws/r/7ckZ #EBP #PCP #nurse #pharm
Advertisement
